New research has just surfaced from Johns Hopkins indicating that there is likely a link between prenatal exposure to antidepressant drugs and autism spectrum disorder (ASD) as well as other developmental delays (DD) among boys. This is highly concerning for pregnant mothers who have made the choice to stay on antidepressants throughout their pregnancy, particularly …
It’s no secret that depression is becoming one of the biggest epidemics in the United States and throughout the world. Many people suffer from mental illnesses, but depression is a condition that seems to affect everyone at some point in their lives. Unfortunately there is no pill that will cure depression, but there are various …
Pharmaceutical companies spend exorbitant sums of money developing new drugs. Getting a drug through clinical trials and proving that it works can take millions, or in other cases, billions of dollars. When a drug does get approval, the pharmaceutical company typically makes back significantly more money than they spent on development for the drug. This …
PMS (Premenstrual Syndrome) is a condition characterized by unwanted symptoms such as mood swings, fatigue, food cravings, irritability, and depression. These symptoms tend to occur during the second half of a woman’s menstrual cycle and tend to subside approximately a couple days after the start of the menstrual period. As of now, these current symptoms …
Dopamine Reuptake Inhibitors (DRIs) are drugs that function by preventing the reuptake of the neurotransmitter dopamine. The fact that they prevent dopamine reuptake leads to increased concentrations of dopamine between synapses. This increases stimulation of the central nervous system and tends to improve cognitive function, alertness, and performance. These medications are most often utilized for …
Norepinephrine Dopamine Reuptake Inhibitors (NDRIs) are drugs that function by inhibiting the reuptake of the neurotransmitters norepinephrine and dopamine. This leads to increased neural concentrations of these activating neurotransmitters, resulting in increased stimulation of the central nervous system. Certain NDRIs inhibit reuptake of norepinephrine to a greater extent than dopamine (and vice versa). Others may have …
Norepinephrine Reuptake Inhibitors (NRIs) are drugs that function primarily by inhibiting the reuptake of the neurotransmitter norepinephrine (noradrenaline) and/or epinephrine (adrenaline). Inhibiting the reuptake of norepinephrine tends to elicit stimulating effects, thereby increasing both cortical arousal and energy levels. The NRI drugs are typically prescribed to individuals that may benefit from increased arousal such as …